Literature DB >> 1435671

Incidence of treatment for end-stage renal disease attributed to diabetes mellitus, by race/ethnicity--Colorado, 1982-1989.

.   

Abstract

Diabetes mellitus (DM) is the principal known cause of end-stage renal disease (ESRD) (i.e., renal insufficiency requiring kidney dialysis or transplantation for survival) and accounts for one third of all incident cases of treated ESRD in the United States. Rates for initiating diabetes-related ESRD (ESRD-DM) treatment have been characterized for blacks and whites but have not been well characterized for Hispanics. To describe ESRD-DM treatment by race/ethnicity in Colorado for improved program planning for intervention services, the Colorado Diabetes Surveillance Project of the Colorado Department of Health investigated differences in the rates of initiating ESRD-DM treatment for non-Hispanic white, Hispanic, and black Colorado residents with diabetes. This report describes trends in the incidence of ESRD-DM treatment by race/ethnicity among persons with diabetes in Colorado from 1982 through 1989.

Entities:  

Mesh:

Year:  1992        PMID: 1435671

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  3 in total

1.  Estimating the concentration of urea and creatinine in the human serum of normal and dialysis patients through Raman spectroscopy.

Authors:  Maurício Liberal de Almeida; Cassiano Junior Saatkamp; Adriana Barrinha Fernandes; Antonio Luiz Barbosa Pinheiro; Landulfo Silveira
Journal:  Lasers Med Sci       Date:  2016-07-08       Impact factor: 3.161

2.  Ethnic disparity in outcomes for pediatric peritoneal dialysis patients in the ESRD Clinical Performance Measures Project.

Authors:  Meredith A Atkinson; Alicia M Neu; Barbara A Fivush; Diane L Frankenfield
Journal:  Pediatr Nephrol       Date:  2007-09-18       Impact factor: 3.714

Review 3.  The Incidence of End-Stage Renal Disease in the Diabetic (Compared to the Non-Diabetic) Population: A Systematic Review.

Authors:  Maria Narres; Heiner Claessen; Sigrid Droste; Tatjana Kvitkina; Michael Koch; Oliver Kuss; Andrea Icks
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.